Integration of Mental Health in HIV Clinic to Increase the Success of ARV Treatment in PLWHA in Hospitals
NCT ID: NCT04331782
Last Updated: 2020-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2019-07-22
2019-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main purpose of this study is to estimate the proportion of depressive disorders in people living with HIV. The study included adult HIV patients aged ≥18 years, both men and women, who had received ARV treatment for at least six months, with no history of being diagnosed with depression.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
NCT05570812
Clinical Trials to Evaluate Metformin to Treat Depression in People Living With HIV
NCT07007221
Sleep Disorders and Psychophysical Well-being in HIV+ Patients
NCT05835232
Randomized Controlled Trial of Stress Management Training in HIV
NCT00436085
A Study of the Long-Term Outcomes of HIV-Positive Patients
NCT00000932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients from HIV outpatient clinics in each research hospital were briefed on the study and offered to participate. Furthermore, based on the assessment of inclusion and exclusion criteria, PLWHA who meet the requirements were recruited and data were collected.
Sociodemographic data, HIV risk factors, risk behaviors, clinical characteristics such as duration of HIV, family history of mental illness, AIDS-related illnesses, other serious non-AIDS-related illnesses, treatment (antiretroviral (ARV) and non-ARV) and history ARV treatment response (HIV and CD4 viral load) were collected from each participant. In addition, a rapid screening for depressive disorders was carried out using the Patient Health Questionnaire-9 (PHQ-9) which was translated and validated in Indonesian. The PHQ-9 questionnaire was filled in by the patient with the assistance of health personnel. The total PHQ-9 questionnaire score were added up and the severity of depression associated with the score was reported to the patient's physician for further management.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. HIV positive based on diagnosis standards of care in research hospitals.
3. Have received ARV treatment for at least six months.
4. Without a history of being diagnosed with a depressive disorder beforehand.
5. Has been given an explanation before the research and give approval after the explanation.
Exclusion Criteria
2. Currently undergoing a period of detention.
3. Being seriously ill (according to the doctor's justification at the hospital).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
OTHER
Ina-Respond
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr. Muhammad Karyana, MPH
Role: PRINCIPAL_INVESTIGATOR
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Site 600 : Adam Malik Hospital
Medan, North Sumatra, Indonesia
Site 650: Budi Kemuliaan Hospital
Batam, Riau Islands, Indonesia
Site 630: M. Ansari Saleh Hospital
Banjarmasin, South Kalimantan, Indonesia
Site 640: St. Carolus Hospital
Jakarta, , Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INA104.02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.